Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| GPCR rhodopsin (GPCR-1) | ||||||
| Adrenergic receptor beta-3 (ADRB3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Agonist (CL-316,243) of Adrb3 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that agonist of ADRB3 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
| Hydrolases (EC 3) | ||||||
| Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
| Details | It is reported that knockdown of GGT1 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
| Sulfatase sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Knockdown (shRNA) of SULF1 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase (FC = 10.68) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
| Details | It is reported that knockdown of SULF1 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
| Organophosphate:Pi antiporter (OPA) | ||||||
| Glucose-6-phosphate translocase (SLC37A4) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Overexpression of SLC37A4 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that overexpression of SLC37A4 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
| Sugar transporter (ST) | ||||||
| Facilitated glucose transporter 1 (SLC2A1A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Downregulation of slc2a1a caused by Yap loss-of-function mutation | |||||
| Induced Change | Glucose 6-phosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that downregulation of slc2a1a caused by Yap loss-of-function mutation leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
| Transcription factor (TF) | ||||||
| Forkhead box protein O1 (FOXO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] | ||||
| Introduced Variation | Overexpression of Foxo1 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase (FC = 3.10) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that overexpression of Foxo1 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
| Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] | ||||
| Introduced Variation | Knockdown (siRNA) of MYC | |||||
| Induced Change | Glucose 6-phosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
| Details | It is reported that knockdown of MYC leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
| Transcriptional coactivator (TC) | ||||||
| Transcriptional coactivator YAP1 (yap1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
| Induced Change | Glucose 6-phosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Acetylglucosaminyltransferase 5 (MGAT5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] | ||||
| Introduced Variation | Knockout of Mgat5 | |||||
| Induced Change | Glucose 6-phosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Mgat5 leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
| Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] | ||||
| Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of Pdxk | |||||
| Induced Change | Glucose 6-phosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
| Details | It is reported that knockout of Pdxk leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
| Transaldolase (TALDO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] | ||||
| Introduced Variation | Knockout of Taldo1 | |||||
| Induced Change | Glucose 6-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Taldo1 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


